Research Overview

Retatrutide (LY3437943) is a novel triple-acting agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies.

Specifications

Quantity: 10mg per vial
Form: Lyophilized powder
Purity: ≥99% (HPLC verified)
Storage: -20°C, protect from light

For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.

Certificate of Analysis (Janoshik)

Independent third-party testing by Janoshik Analytical. Click to view full report.

Retatrutide 10mg Certificate of Analysis — Retatrutide 10mg — Janoshik Analytical

Retatrutide 20mg Certificate of Analysis — Retatrutide 20mg — Janoshik Analytical

Retatrutide 30mg Certificate of Analysis — Retatrutide 30mg — Janoshik Analytical

Shop